Knoops, Laurent
Cliniques Universitaires Saint-Luc · de Duve Institute · UCLouvain
3 papers on CoChat
Most cited papers
- Verified
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
Harrison, C., Kiladjian, J.-J., Al-Ali, H. K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D. S., Levy, R., Knoops, L., et al. (2012) · New England Journal of Medicine
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 1,825
- Verified
Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy
Harrison, C. N., Mesa, R. A., Kiladjian, J., Al‐Ali, H., Gisslinger, H., Knoops, L., Squier, M., Sirulnik, A., Mendelson, E., Zhou, X., et al. (2013) · British Journal of Haematology
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 90
- Verified
B lymphocytes are critical for lung fibrosis control and prostaglandin E2 regulation in IL-9 transgenic mice
Arras, M., Louahed, J., Simoen, V., Barbarin, V., Misson, P., van den Brûle, S., Delos, M., Knoops, L., Renauld, J.-C., Lison, D., et al. (2006) · American Journal of Respiratory Cell and Molecular Biology
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases
Cited by 46
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free